Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


New FDA commissioner appointed

Robert Califf has been confirmed as the new commissioner of the US Food and Drug Administration (FDA). 

The United States Senate approved the appointment on 24 February 2016 after months of debate.

Acting FDA commissioner Stephen Ostroff welcomed the appointment. “Dr Califf has demonstrated a long and deep commitment to advancing the public health throughout his distinguished career as a physician, researcher, and leader in the fields of science and medicine,” he said in a statement. 

Califf’s previous role was as deputy commissioner for medical products and tobacco at the FDA and he was then nominated for the commissioner role by US President Barack Obama in September 2015. The nomination was met with opposition from some senators who objected to Califf’s ties to the pharmaceutical industry and what they saw as the FDA’s failure in controlling the opioid abuse epidemic sweeping the United States. In response to the concerns, Califf released a plan of action to tackle opioid abuse on 4 February 2016. 

As a professor at Duke University, Califf specialised in cardiology and is recognised as an “international leader in cardiovascular medicine, health outcomes, healthcare quality and medical economics,” according to the US National Institutes of Health. However, Califf has also presided over several clinical trial initiatives that have strongly tied him to the pharmaceutical industry. In a recent publication in the New England Journal of Medicine, he had at least 12 pharmaceutical companies listed on his conflicts of interest disclosure.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20200771

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Paediatric Drug Handling

    Paediatric Drug Handling

    Written for new pharmaceutical scientists, this book provides a background in paediatric pharmacy and a comprehensive introduction to children's medication.

    £33.00Buy now
  • Foundation in Pharmacy Practice

    Foundation in Pharmacy Practice

    A practical and succinct overview of the principal pharmacy practice topics, for new pharmacy students.

    £33.00Buy now
  • Non-medical Prescribing

    Non-medical Prescribing

    An essential new guide designed to ensure confident prescribing in specialist areas.

    £27.00Buy now
  • Dale and Appelbe's Pharmacy and Medicines Law

    Dale and Appelbe's Pharmacy and Medicines Law

    This new edition of Dale and Appelbe's Pharmacy and Medicines Law is the definitive guide to law and ethics for pharmacy practice in the UK. It covers law and professional regulation and is firmly established as the definitive student textbook and reference work on this subject in the UK. Fully updated to include changes to pharmacy laws and regulation.

    £57.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Robert Califf, the new commissioner of the US Food and Drug Administration

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.